ROMK Activators are a category of compounds that can indirectly influence the activity of the Renal Outer Medullary Potassium (ROMK) channel, or Kir1.1, a key protein involved in potassium transport in the nephrons of the kidney. These substances generally operate through pathways linked to electrolyte balance and cellular signaling, which in turn can impact ROMK function. Vasopressin, for instance, can stimulate aldosterone release which promotes the synthesis and trafficking of ROMK channels to the cell membrane, thereby increasing their activity. Similarly, Angiotensin II triggers the renin-angiotensin-aldosterone system (RAAS), a crucial regulator of potassium homeostasis, indirectly influencing ROMK activity. Other compounds, such as Forskolin and 8-Bromo-cyclic AMP, operate via the cAMP-protein kinase A (PKA) pathway. Forskolin elevates intracellular cAMP levels, which then activate PKA, while 8-Bromo-cyclic AMP is a cell-permeable cAMP analog that directly activates PKA. Both can impact the phosphorylation state of ROMK and thus its activity.
Polyunsaturated fatty acids, specifically Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA), can indirectly activate ROMK by modifying the lipid environment of the channel. This modification can affect the channel's conformation and function, leading to changes in its activity. Prostaglandin E2 (PGE2) can also indirectly influence ROMK by modulating cAMP production, leading to changes in PKA activity, and subsequently, ROMK function. Lastly, neurotransmitters such as Acetylcholine and Phenylephrine can indirectly affect ROMK through their modulation of the parasympathetic and sympathetic nervous systems, respectively, which play roles in maintaining electrolyte balance. Taken together, these ROMK Activators illustrate the complex interplay of various cellular processes and signaling pathways that can influence the activity of the ROMK channel indirectly. They underscore the importance of context and the cellular environment in shaping the impact of these compounds on ROMK function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vasopressin | 11000-17-2 | sc-356188 sc-356188A | 5 mg 25 mg | $260.00 $1040.00 | 1 | |
Vasopressin can increase the activity of ROMK indirectly by stimulating the release of aldosterone. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II can indirectly influence ROMK activity by stimulating the renin-angiotensin-aldosterone system (RAAS), which regulates potassium homeostasis. | ||||||
Aldosterone | 52-39-1 | sc-210774 sc-210774A sc-210774B sc-210774C sc-210774D sc-210774E | 2 mg 5 mg 10 mg 50 mg 100 mg 250 mg | $259.00 $213.00 $317.00 $1550.00 $3074.00 $7637.00 | 1 | |
Aldosterone can increase ROMK activity indirectly by promoting the synthesis and trafficking of ROMK channels to the cell membrane. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can indirectly affect ROMK by affecting insulin signaling pathways, which are intimately linked to potassium homeostasis. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine can indirectly affect ROMK by stimulating the sympathetic nervous system, which influences electrolyte balance. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can indirectly affect ROMK by activating protein kinase A (PKA) and modulating the phosphorylation state of ROMK. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that can activate PKA and thereby influence ROMK activity. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
EPA is a polyunsaturated fatty acid that can indirectly activate ROMK by modifying the lipid environment of the channel. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Like EPA, DHA can indirectly activate ROMK by modifying the lipid environment of the channel. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 can indirectly influence ROMK by modulating cAMP production and PKA activity. | ||||||